Sector revisions Perspective Therapeutics, Inc.
Stocks
CATX
US46489V3024
Biotechnology & Medical Research
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.990 USD | +1.36% |
|
-0.66% | +8.73% |
| Jul. 17 | Perspective Therapeutics Data On 212Pb VMT-a-NET Accepted For Oral Presentation At ESMO Congress 2026 | CI |
| Jul. 08 | Perspective Therapeutics, Inc. Announces Executive Changes | CI |
Main competitors
| 1m. Revenue rev. | 4m. EPS revision | 4m. Revenue rev. | 1y. EPS revision | 1y. Revenue rev. | Visibility | Nbr of analysts | ||
|---|---|---|---|---|---|---|---|---|
| 15 | ||||||||
| 22 | ||||||||
| 27 | ||||||||
| 19 | ||||||||
| 24 | ||||||||
| - | 18 | |||||||
| 12 | ||||||||
| 14 | ||||||||
| 16 | ||||||||
| 6 | ||||||||
| 12 | ||||||||
| 15 | ||||||||
| 12 | ||||||||
| 16 | ||||||||
| 11 | ||||||||
| 21 | ||||||||
| 20 | ||||||||
| 17 | ||||||||
| 19 | ||||||||
| 14 | ||||||||
| Average | 16 | |||||||
| Weighted average by Cap. | 18 |
- Stock Market
- Stocks
- CATX Stock
- Sector Perspective Therapeutics, Inc.
- Sector revisions
Select your edition
All financial news and data tailored to specific country editions
















